A team led by University Distinguished Professor of Biology Kim Lewis received a five-year, $9 million grant from the National Institute of Health’s National Institute of Allergy and Infectious Diseases to launch a novel platform for developing antibiotics that kill pathogens without encountering resistance.
Reports of the arrival in the U.S. of a new superbug that is resistant to an antibiotic of last resort have set off alarm bells among public health officials. Last year, a team led by Northeastern professor Kim Lewis discovered teixobactin, an antibiotic that eliminates bacteria without encountering any detectable resistance. We asked him to explain the new superbug, how worried we should be, and how it might be stopped.
Northeastern researcher Kim Lewis and his team have launched an all-out effort to find a cure for Lyme disease, which afflicts nearly 300,000 new people in the U.S. each year. Their efforts aim to bring relief to all patients, including those who suffer from a debilitating chronic version of the disease.
Groundbreaking scientific research published earlier this year by Northeastern researchers and their colleagues topped the list of the 100 scientific articles receiving the most media buzz and online attention in 2015, according to the London-based company Altmetric.
University Distinguished Professor Kim Lewis and his colleagues match findings in the lab with ones from human subjects to advance customized antibiotic treatments.
A research team led by University Distinguished Professor Kim Lewis present in a new paper that they’ve identified drug-tolerant persister cells in the bacterium that causes Lyme disease. They also present a promising approach to potentially eradicating this and other infections.
Northeastern University Distinguished Professor Kim Lewis and his team’s pioneering research presenting a new antibiotic that kills pathogens without encountering any detectable resistance has captured headlines worldwide and drawn widespread praise from the scientific community.
News outlets worldwide and the scientific community have taken notice of new breakthrough research from Northeastern and collaborators in the U.S. and Europe that presents a new antibiotic that eliminates pathogens without encountering any detectable resistance.
The discovery of this novel compound challenges long-held scientific beliefs and holds great promise for treating an array of menacing infections, says Northeastern University Distinguished Professor Kim Lewis.
Four professors in the College of Science explained what drives their passion for science and discovery at a campus event Thursday night.
University Distinguished Professor of Biology Kim Lewis is exploring alternative approaches to curing chronic Lyme disease using his expertise in bacterial cell persistence.
Northeastern biologists have developed a method for treating intractable chronic infections, which kill more than tens of thousands of Americans each year.
Three Northeastern spinoffs were highlighted in a new report from The Science Coalition as examples of how federally funded university research and the companies created from that work can boosts the U.S. economy.
In recent years, the notion that there is a single mechanism by which antibiotics wipe out bacteria has permeated the field of microbiology. Now, new research from professor Kim Lewis and his team questions that hypothesis.
Director of Northeastern’s Antimicrobial Discovery Center elected to the American Academy of Microbiology on the strength of his research achievements
President Aoun calls students, faculty and staff a “powerful force” for innovative research, academic excellence and engagement on campus and across the world.
Biologist Kim Lewis hopes to grow previously uncultivatable gut microorganisms in the lab
Biology professor receives new grant to develop antibiotics that can kill resistant tuberculosis strains
Northeastern research team identifies, for the first time, a mechanism that enables new forms of bacteria to grow in lab
Northeastern researchers discover a protein that enables bacteria to re-infect patients even after aggressive antibiotic treatments
Northeastern biologist to research how certain bacteria populations survive antibiotic treatment
Slava Epstein wouldn’t be mistaken for Indiana Jones, but a few minutes in his company, examining an Amazonian bow and arrow that reaches to his ceiling tiles, a stone axe […]
Research aims to translate naturally occurring process in plants into human antibacterial treatment for potentially fatal infection
Northeastern University Receives $100,000 Grand Challenges Exploration Grant for Innovative Global Health Research by Professor Kim Lewis
Northeastern University announced today that it has received a $100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The grant will support an innovative global health research […]
Northeastern University Postdoctoral Associate Receives Prestigious Award from the Cystic Fibrosis Foundation
Boston, Mass. — Dr. Lawrence Mulcahy of Northeastern University’s Antimicrobial Discovery Center and Department of Biology, has received an esteemed Postdoctoral Fellowship Award from the Cystic Fibrosis Foundation, the leading […]
Northeastern University Professor Receives $1.4 MillionNIH Grant to Study Genetics of Resistant Bacteria
BOSTON – April 10, 2008 – Dr. Kim Lewis, Professor of Biology and Director of the Antimicrobial Center at Northeastern University, has been awarded a $1.4 million grant from the […]
Scientists find innovative method for cultivating bacteria Two Northeastern University researchers have discovered a way to domesticate “stubborn” microbial species. The revolutionary method capitalizes on their earlier technology to grow […]
University Research Team is One of 11 Grantees Sharing the $280 Million Fund Northeastern University announced today that Dr. Kim Lewis, Professor of Biology and Director of the Antimicrobial Center, is […]